@>Russ< and @Stewart
AHZ was not 100% owner of the immunotherapies so we are part of the original shareholder group that now owns 40%.
Consider this as a capital raise for the immunotherapies entity which has sold newly issued shares for $18m. That has diluted AHZ to 29.1% (I can't remember AHZ's initial % holding in this entity but think it was something like 75%). The money goes to the immunotherapy entity so whilst on one hand AHZ owns a smaller amount of this pie, on the other hand the entity has become a bigger pie now.
Importantly this will mean that AHZ won't have to keep ploughing funding into the immunotherapy entity because it now has $18m in its accounts.
- Forums
- ASX - By Stock
- AVR
- Ann: MOU signed for Admedus Vaccines
Ann: MOU signed for Admedus Vaccines, page-8
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M |
Open | High | Low | Value | Volume |
$13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1150 | $14.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.25 | 314 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1150 | 14.100 |
1 | 364 | 13.700 |
1 | 100 | 13.400 |
1 | 60 | 13.150 |
1 | 50 | 13.120 |
Price($) | Vol. | No. |
---|---|---|
14.250 | 314 | 1 |
15.000 | 1000 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |